{"id":329000,"date":"2026-10-28T09:09:39","date_gmt":"2026-10-28T03:39:39","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/concord-biotech-q2-results-fy27-pat-70-crore\/"},"modified":"2026-10-28T09:09:39","modified_gmt":"2026-10-28T03:39:39","slug":"concord-biotech-q2-results-fy27-pat-70-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/concord-biotech-q2-results-fy27-pat-70-crore\/","title":{"rendered":"Concord Biotech Q2 Results FY27: Revenue Up 25.1% to Rs 309.07 Cr, PAT Rs 69.57 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Concord Biotech Q2 Results FY27 were declared on 27 October 2026 and cover the July to September 2026 quarter on a consolidated basis. Revenue rose 25.1% YoY to Rs 309.07 Cr, while net profit increased 10.32% YoY to Rs 69.57 Cr. These quarterly results show YoY growth in both lines, with revenue growing faster than net profit, and Operating Profit stood at Rs 104.38 Cr.<\/p>\n<\/div>\n

Concord Biotech Ltd<\/a> (CONCORDBIO) Q2 Results FY27 announced on 27 October 2026, covering the company’s financial performance for the July to September quarter. The consolidated results show revenue of Rs 309.07 Cr against Rs 247.06 Cr in the same quarter last year, and net profit of Rs 69.57 Cr against Rs 63.06 Cr. Concord Biotech Q2 Results FY27 therefore arrive with a results date of 27 October 2026 and a clear lead for revenue over profit.<\/p>\n

This results analysis of Concord Biotech Q2 Results covers the financial highlights, the business drivers, the outlook and the risks. It begins with the Financial Highlights table that follows, where revenue, Operating Profit and net profit sit side by side with the same quarter of last year.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n